Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
19.17
Nov 17 • 3:59 PM ET Dollar change-0.79 Percentage change(-3.96%)
Aftermarket Close
19.17
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
34.37M
Enterprise Value
34.48M
Income
-1.14M
Sales
27.76M
Book/sh
8.29
Cash/sh
2.00
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
61
IPO
Jul 18, 2000
P/E
-
Forward P/E
-
PEG
-
P/S
1.24
P/B
2.31
P/C
9.60
P/FCF
24.73
EV/EBITDA
84.11
EV/Sales
1.24
Quick Ratio
1.54
Current Ratio
1.77
Debt/Eq
0.25
LT Debt/Eq
0.19
Option/Short
No / Yes
EPS (ttm)
-0.64
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
72.37% 57.83%
Sales past 3/5Y
36.71% 31.60%
EPS Y/Y TTM
22.97%
Sales Y/Y TTM
21.76%
EPS Q/Q
90.66%
Sales Q/Q
8.33%
Insider Own
12.57%
Insider Trans
-1.76%
Inst Own
24.37%
Inst Trans
2.01%
ROA
-5.34%
ROE
-8.00%
ROIC
-6.45%
Gross Margin
37.74%
Oper. Margin
-5.34%
Profit Margin
-4.12%
SMA20
-5.24%
SMA50
-15.39%
SMA200
-22.59%
Trades
Shs Outstand
1.79M
Shs Float
1.57M
52W High
33.63 -43.00%
52W Low
17.79 7.76%
Volatility
10.87% 7.88%
ATR (14)
1.77
RSI (14)
41.98
Beta
1.40
Rel Volume
0.51
Avg Volume
90.08K
Volume
46,292
Perf Week
-18.94%
Perf Month
-12.43%
Perf Quarter
-31.17%
Perf Half Y
-22.33%
Perf YTD
-16.58%
Perf Year
-8.84%
Perf 3Y
169.81%
Perf 5Y
-52.78%
Perf 10Y
-98.75%
Prev Close
19.96
Price
19.17
Change %
-3.96%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SANDBERG RICHARD ADirectorMay 21 '26Sale25.0290022,5173,000May 26 04:00 PM
SANDBERG RICHARD ADirectorMay 20 '26Sale24.892,03450,6328,142May 21 04:00 PM
SANDBERG RICHARD ADirectorMay 19 '26Sale24.4260014,6524,400May 21 04:00 PM
SANDBERG RICHARD ADirectorMay 20 '26Sale25.0050012,5003,900May 21 04:00 PM
SANDBERG RICHARD ADirectorMay 19 '26Proposed Sale24.854,034100,245May 19 02:19 PM
Sabet Ahmed ZakiChief Operating OfficerApr 01 '26Buy27.93195311,034Apr 10 04:00 PM
Sabet Ahmed ZakiChief Operating OfficerJan 02 '26Buy23.4020468735Jan 06 04:34 PM
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. It operates through the following business divisions: Pathology Services and Products. The Pathology Services division provides specialized cancer diagnostic testing services to physicians, hospitals, and laboratories. The Products divisions develops and commercializes proprietary assays designed for use by clinical laboratories. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
FounderMr. Ilan Danieli
Chief Operating OfficerMr. Ahmed Zaki Sabet
Chief Technology OfficerDr. Ayman A. Mohamed M.D.
Chief Financial OfficerMr. Matthew Gage
Chief Legal Counsel & People OfficerMs. Miri Chiko-Radomski